You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

BONTRIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Bontril, and when can generic versions of Bontril launch?

Bontril is a drug marketed by Valeant and is included in two NDAs.

The generic ingredient in BONTRIL is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Drug patent expirations by year for BONTRIL
Recent Clinical Trials for BONTRIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
William StoopsPhase 1
University of KentuckyPhase 1
National Institute on Drug Abuse (NIDA)Phase 1

See all BONTRIL clinical trials

US Patents and Regulatory Information for BONTRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant BONTRIL phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 088021-001 Sep 21, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Valeant BONTRIL PDM phendimetrazine tartrate TABLET;ORAL 085272-001 Approved Prior to Jan 1, 1982 AA RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.